OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
OxfordOxford Mon - Fri 09:00-17:00 +44(0)1865-600222
J Venom Res
The Eur J Extracellular Vesicles
Submit a manuscript

Speakers & Agenda

Provisional Agenda

(Subject to change)

09.20:    Registration, welcome coffee, networking

10.20:    Welcome and housekeeping

Session 1: Chair Raymond Schiffelers

10.30:    Professor Raymond Schiffelers, Professor of Nanomedicine, Clinical Chemistry and Haematology, UMC Utretch, The Netherlands

Steering extracellular vesicle uptake

11.00:    Dr David Carter, Reader, Department of Biological and Medical Sciences, Oxford Brookes University, UK

Identification of vesicular ncRNA and protein that may contribute to the radiation-induced bystander effect

11.30:    Dr Sonja Petkovic, Institute for Molecular Medicine, University of Lübeck, Germany

Identification of a circRNA: ciRS-7-“the sponge“ in several types of cells

12.00:    Professor Alfonso Jaramillo, Professor of Synthetic Biology, University of Warwick, United Kingdom and Directeur de Recherche CNRS, ISSB, France

Title TBA

12.30:    Lunch and networking

Session 2: Chair Professor Andrew Miller

13.30:    Professor Chris Murphy, Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK

MicroRNAs and cartilage

14.00:   Professor Stephen Hart, Professor, UCL Institute of Child Health, London, UK

RNA interference as a therapy for cystic fibrosis

14.30:    Dr Carlo Rinaldi, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK

RNA-silencing strategies to treat polyglutamine diseases

15.00:    Dr Fanny Caffin, Institute for Radiological Protection and Nuclear Safety (IRSN), FRANCE

Expression profile of microRNAs in endothelial cells and their role in radiation damage to healthy tissue

15.20:    Refreshment Break

Session 3: Chair Dr David Carter

15.50:    Professor Andrew Miller, Founder and Chief Scientific Officer, GlobalAcorn Ltd (Advanced Therapeutics), UK, and Professor of Biochemistry, King’s College London, UK

Are lipid-based nanoparticles (LNPs) still useful for the functional delivery of bio-active pharmaceutical ingredients (bio-APIs) in vivo?

16.20:    Professor Francesca Meteora Buffa, Assistant Professor of Computational Biology and Integrative Genomics, Department of Oncology, University of Oxford, Oxford, UK

Aberrant microRNA biogenesis machinery in cancer

16.50:    Dr Patrick Baril, Lecturer, Centre de Biophysique Moléculaire, CNRS, Université d’Orléans and Inserm, Orléans, France

RILES, a novel engineered genetic-switch expression system for the temporal analysis of microRNA expression in small animal model

17.10:    Dr Tobias PoehlmannFriedrich-Schiller-University of Jena, Spin-off project “Intelligent siRNA”, Jena, Germany

Development of Tumor-toxic miRNA mimics

17.30:    Miss Rachel Anne Valenzuela, University of California (Davis), USA

Controlling miRNA-like Off-target Effects of an siRNA with Nucleobase Modifications

17.50:    Dr Muhammad Z DanishAssistant Professor, University College of Pharmacy, University of the Punjab, Lahore, Pakistan,

Complexation and binding behaviour of different nucleic acids using PAA based self-assembling cationic nanoparticles for gene therapy

18.10:    Dr Muhasin Asaf, Assistant Professor, College of Veterinary & Animal Sciences, Kerala Veterinary & Animal Sciences University, India

Validation of Pulmonary miRNAs  upregulated in Chicken During Highly Pathogenic Avian Influenza Virus (H5N1)  Infection and Functional Annotation of Their Target Genes